Risk Factors for Major Adverse Cardiovascular Events, Malignancies, and Serious Infections With Tofacitinib in Rheumatoid Arthritis: Post Hoc Analysis of a 3‐Year J‐Post‐Marketing Surveillance
Kunihiro Yamaoka(Kitasato University), Toshitaka Hirano(Pfizer (Japan))
Cited by 1
Related Papers
No related papers found
Powered by citation graph analysis